EBOS Group Limited
EBOS Group Limited (EBOSY) Revenue
Annual & quarterly revenue history · segment & region breakdown
EBOSY · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsEBOS Group Limited trailing twelve-month (TTM) revenue is $25.64B, a decrease of 7.23% year-over-year from $12.20B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-06-30 | $12.20B | -$0.95B | -7.23% |
| 2024-06-30 | $13.15B | +$0.90B | +7.34% |
| 2023-06-30 | $12.25B | +$0.35B | +2.90% |
| 2022-06-30 | $11.90B | +$2.69B | +29.16% |
| 2021-06-30 | $9.21B | -$0.17B | -1.78% |
| 2020-06-30 | $9.38B | +$2.45B | +35.37% |
| 2019-06-30 | $6.93B | -$0.07B | -0.99% |
| 2018-06-30 | $7.00B | -$0.63B | -8.20% |
| 2017-06-30 | $7.63B | +$0.52B | +7.38% |
| 2016-06-30 | $7.10B | +$1.03B | +17.03% |
Compare revenue vs peers
Medical - DistributionCompare EBOSY revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income EBOS Group Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
EBOS Group Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in AUD.
Data sourced from EBOS Group Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
EBOSY revenue · 4 questionsEBOSY's trailing twelve-month (TTM) revenue is $25.64B. That is a decrease of 7.23% year-over-year from $12.20B in FY2025.
▸ Source: FMP · EBOS Group Limited SEC filings · GAAP · EBOS Group Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026